Vanguard Group Inc. Has $157.23 Million Stock Holdings in Teladoc Health, Inc. $TDOC

Vanguard Group Inc. boosted its position in Teladoc Health, Inc. (NYSE:TDOC) by 7.0% during the first quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 19,752,338 shares of the health services provider’s stock after buying an additional 1,289,183 shares during the quarter. Vanguard Group Inc. owned approximately 11.26% of Teladoc Health worth $157,229,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors have also bought and sold shares of the company. Cambridge Investment Research Advisors Inc. boosted its position in Teladoc Health by 60.8% during the first quarter. Cambridge Investment Research Advisors Inc. now owns 39,738 shares of the health services provider’s stock valued at $316,000 after purchasing an additional 15,030 shares during the last quarter. Golden State Wealth Management LLC boosted its position in Teladoc Health by 102.6% during the first quarter. Golden State Wealth Management LLC now owns 3,337 shares of the health services provider’s stock valued at $27,000 after purchasing an additional 1,690 shares during the last quarter. Wedmont Private Capital boosted its position in Teladoc Health by 20.3% during the first quarter. Wedmont Private Capital now owns 16,086 shares of the health services provider’s stock valued at $117,000 after purchasing an additional 2,715 shares during the last quarter. Wealth Enhancement Advisory Services LLC boosted its position in Teladoc Health by 22.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 14,725 shares of the health services provider’s stock valued at $134,000 after purchasing an additional 2,662 shares during the last quarter. Finally, Vontobel Holding Ltd. boosted its position in Teladoc Health by 61.4% during the first quarter. Vontobel Holding Ltd. now owns 21,422 shares of the health services provider’s stock valued at $171,000 after purchasing an additional 8,152 shares during the last quarter. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Trading Down 1.7%

Shares of TDOC stock opened at $7.2150 on Thursday. The firm has a 50 day moving average price of $7.72 and a two-hundred day moving average price of $8.26. The company has a quick ratio of 2.58, a current ratio of 2.67 and a debt-to-equity ratio of 0.70. The company has a market capitalization of $1.27 billion, a PE ratio of -6.06 and a beta of 1.76. Teladoc Health, Inc. has a 12-month low of $6.35 and a 12-month high of $15.21.

Teladoc Health (NYSE:TDOC) last announced its earnings results on Tuesday, July 29th. The health services provider reported ($0.19) earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of ($0.27) by $0.08. Teladoc Health had a negative net margin of 8.16% and a negative return on equity of 10.13%. The firm had revenue of $631.90 million for the quarter, compared to analyst estimates of $621.91 million. During the same quarter in the prior year, the business posted ($0.38) EPS. The business’s revenue was down 1.6% compared to the same quarter last year. Teladoc Health has set its Q3 2025 guidance at -0.350–0.200 EPS. FY 2025 guidance at -1.350–1.000 EPS. As a group, analysts predict that Teladoc Health, Inc. will post -1.16 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Citigroup lowered their price target on Teladoc Health from $11.00 to $8.75 and set a “neutral” rating on the stock in a research report on Friday, April 25th. Truist Financial lowered their price target on Teladoc Health from $10.00 to $9.00 and set a “hold” rating on the stock in a research report on Tuesday, May 27th. Needham & Company LLC reissued a “hold” rating on shares of Teladoc Health in a research report on Thursday, May 1st. Bank of America lowered their price target on Teladoc Health from $8.00 to $7.00 and set a “neutral” rating on the stock in a research report on Wednesday, May 28th. Finally, Evercore ISI boosted their price target on Teladoc Health from $7.00 to $8.00 and gave the stock an “in-line” rating in a research report on Wednesday, July 9th. Six research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat.com, Teladoc Health currently has an average rating of “Hold” and an average target price of $9.75.

Insider Activity

In other news, insider Fernando M. Rodrigues sold 4,174 shares of the company’s stock in a transaction that occurred on Tuesday, June 3rd. The stock was sold at an average price of $6.91, for a total value of $28,842.34. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, insider Adam C. Vandervoort sold 5,808 shares of the company’s stock in a transaction that occurred on Monday, June 2nd. The shares were sold at an average price of $6.86, for a total value of $39,842.88. Following the completion of the transaction, the insider directly owned 69,773 shares of the company’s stock, valued at $478,642.78. This represents a 7.68% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 18,656 shares of company stock worth $128,189. Corporate insiders own 0.58% of the company’s stock.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.